Pililis, S.; Lampsas, S.; Kountouri, A.; Pliouta, L.; Korakas, E.; Livadas, S.; Thymis, J.; Peppa, M.; Kalantaridou, S.; Oikonomou, E.;
et al. The Cardiometabolic Risk in Women with Polycystic Ovarian Syndrome (PCOS): From Pathophysiology to Diagnosis and Treatment. Medicina 2024, 60, 1656.
https://doi.org/10.3390/medicina60101656
AMA Style
Pililis S, Lampsas S, Kountouri A, Pliouta L, Korakas E, Livadas S, Thymis J, Peppa M, Kalantaridou S, Oikonomou E,
et al. The Cardiometabolic Risk in Women with Polycystic Ovarian Syndrome (PCOS): From Pathophysiology to Diagnosis and Treatment. Medicina. 2024; 60(10):1656.
https://doi.org/10.3390/medicina60101656
Chicago/Turabian Style
Pililis, Sotirios, Stamatios Lampsas, Aikaterini Kountouri, Loukia Pliouta, Emmanouil Korakas, Sarantis Livadas, John Thymis, Melpomeni Peppa, Sophia Kalantaridou, Evangelos Oikonomou,
and et al. 2024. "The Cardiometabolic Risk in Women with Polycystic Ovarian Syndrome (PCOS): From Pathophysiology to Diagnosis and Treatment" Medicina 60, no. 10: 1656.
https://doi.org/10.3390/medicina60101656
APA Style
Pililis, S., Lampsas, S., Kountouri, A., Pliouta, L., Korakas, E., Livadas, S., Thymis, J., Peppa, M., Kalantaridou, S., Oikonomou, E., Ikonomidis, I., & Lambadiari, V.
(2024). The Cardiometabolic Risk in Women with Polycystic Ovarian Syndrome (PCOS): From Pathophysiology to Diagnosis and Treatment. Medicina, 60(10), 1656.
https://doi.org/10.3390/medicina60101656
